Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $24,336 - $33,557
125 New
125 $33,000
Q2 2022

Aug 11, 2022

SELL
$187.54 - $223.02 $23,442 - $27,877
-125 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $24,221 - $30,517
125 New
125 $26,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track De Burlo Group Inc Portfolio

Follow De Burlo Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.